Per Gunnar Falk
President at Ferring Pharmaceuticals A/S
Profile
Per Gunnar Falk is currently the President & Chief Science Officer at Ferring Pharmaceuticals A.
Previously, he held positions as an Associate Director at AstraZeneca AB from 1998 to 2009, Director at Molecular Biology Consultants, Director at Recopharma AB, Director at Astra Hässle AB, and Senior VP-Biopharmaceuticals Research Unit at Novo Nordisk A.
He also served as a Principal at Gastrointestinal Associates PC, Associate Professor at Karolinska Institutet, and Member-Supervisory Board at Innate Pharma SA. Additionally, he was a Faculty Member at Umea Universitet and the University of Gothenburg.
Dr. Falk obtained a doctorate degree from the University of Gothenburg.
Per Gunnar Falk active positions
| Companies | Position | Start |
|---|---|---|
Ferring Pharmaceuticals A/S
 Ferring Pharmaceuticals A/S Pharmaceuticals: MajorHealth Technology Ferring Pharmaceuticals A/S specializes in the development, production and marketing of pharmaceutical products. It offers products in the fields of urology, infertility, obstetrics, gynecology, gastroenterology and maternal health. The company is headquartered in Copenhagen, Denmark. | President | 2018-12-31 |
Former positions of Per Gunnar Falk
| Companies | Position | End |
|---|---|---|
| Novo Nordisk North America, Inc. | Chief Tech/Sci/R&D Officer | 2011-01-02 |
| INNATE PHARMA | Director/Board Member | - |
| NOVO NORDISK A/S | Corporate Officer/Principal | - |
| Molecular Biology Consultants | Director/Board Member | - |
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Director/Board Member | - |
Training of Per Gunnar Falk
| University of Gothenburg | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| NOVO NORDISK A/S | Health Technology |
| INNATE PHARMA | Health Technology |
| Private companies | 7 |
|---|---|
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Commercial Services |
Ferring Pharmaceuticals A/S
Ferring Pharmaceuticals A/S Pharmaceuticals: MajorHealth Technology Ferring Pharmaceuticals A/S specializes in the development, production and marketing of pharmaceutical products. It offers products in the fields of urology, infertility, obstetrics, gynecology, gastroenterology and maternal health. The company is headquartered in Copenhagen, Denmark. | Health Technology |
Gastrointestinal Associates PC
 Gastrointestinal Associates PC Medical/Nursing ServicesHealth Services Gastrointestinal Associates PC provides treatment for gastrointestinal problems. The private company is based in Knoxville, TN. | Health Services |
| Molecular Biology Consultants | |
| Novo Nordisk North America, Inc. | |
Recopharma AB
 Recopharma AB Pharmaceuticals: MajorHealth Technology Recopharma AB is a biotechnology company that develops ophthalmic products based on protein-carbohydrate interactions. It develops a technology that uses mucins, naturally occurring proteins produced by epithelial tissues with many potential applications. The company was founded in 2004 and is headquartered in Huddinge, Sweden | Health Technology |
| Astra Hässle AB |
- Stock Market
- Insiders
- Per Gunnar Falk
